ksg 504 has been researched along with bromodeoxyuridine in 1 studies
| Studies (ksg 504) | Trials (ksg 504) | Recent Studies (post-2010) (ksg 504) | Studies (bromodeoxyuridine) | Trials (bromodeoxyuridine) | Recent Studies (post-2010) (bromodeoxyuridine) |
|---|---|---|---|---|---|
| 13 | 0 | 0 | 13,164 | 71 | 1,816 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bamba, T; Fujiyama, Y; Inoue, H; Okumura, Y | 1 |
1 other study(ies) available for ksg 504 and bromodeoxyuridine
| Article | Year |
|---|---|
Effects of short-term administration of the CCK receptor antagonist, KSG-504, on regeneration of pancreatic acinar cells in acute pancreatitis in rats.
Topics: Acute Disease; Animals; Bromodeoxyuridine; DNA; Ethionine; Male; Naphthalenes; Ornithine Decarboxylase; Pancreas; Pancreatitis; Pentanoic Acids; Rats; Rats, Wistar; Receptors, Cholecystokinin; Regeneration | 1995 |